Tandem Diabetes Care Inc. (TNDM)
NASDAQ: TNDMHealthcareMedical DevicesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
TNDM stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.10B
- Forward P/E
- 99.65
- EPS (TTM)
- -$0.89
- Dividend yield
- None
- 52-week range
- 12.26 – 29.65
- Day range
- 15.73 – 16.64
- Volume / Avg
- 2.27M / 1.98M
- Beta
- —
- Shares outstanding
- 69.58M
- Next earnings
- Nov 5, 2026
52-week range
TNDM stock today
Shares of Tandem Diabetes Care (TNDM) finished lower on Oct 7 at $15.84, a drop of 1.98% or $0.32 per share, versus the S&P 500's 0.22% decline. Shares are 46.6% below their 52-week high of $29.65, set on Feb 24, 2026 and 29.2% above the 52-week low of $12.26, in the middle of the past year's range. TNDM is down 27.9% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 9.1%.
Tandem Diabetes Care has posted a net loss over the last twelve months (EPS of -$0.89), so its P/E ratio is not meaningful. Tandem Diabetes Care's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Tandem Diabetes Care
Company profileTandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system.
- Sector
- Healthcare
- Industry
- Medical Devices
- CEO
- Mr. John F. Sheridan
- Headquarters
- San Diego, CA
- Employees
- 2,500
- IPO year
- 2013
- Website
- tandemdiabetes.com
Analyst forecast
ForecastConsensus (25 analysts)
buy
Avg. price target
$27.86+75.88%
- Strong buy 3
- Buy 11
- Hold 11
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.27
TNDM news
All TNDM newsTandem Diabetes Care peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| IRMDiRadimed Corporation | 85.47 | +0.77% | $1.09B | vs TNDM |
| AORTArtivion Inc. | 21.61 | -1.05% | $1.05B | vs TNDM |
| PRCTPROCEPT BioRobotics Corporation | 17.91 | +2.28% | $1.02B | vs TNDM |
| LMRILumexa Imaging Holdings Inc. | 10.59 | -1.12% | $1.02B | vs TNDM |
| ENOVEnovis Corporation | 17.61 | -3.24% | $1.02B | vs TNDM |
| IARTIntegra LifeSciences Holdings Corporation | 13.00 | -2.40% | $1.01B | vs TNDM |
| BBNXBeta Bionics Inc. | 18.08 | -2.95% | $975.35M | vs TNDM |
| CNMDCONMED Corporation | 44.23 | -0.56% | $1.32B | vs TNDM |
Indexes, lists and sector
Appears in lists
Tandem Diabetes Care stock FAQ
What is Tandem Diabetes Care's stock price today?
TNDM last traded at $15.84 as of Oct 7, 4:00 PM EDT, down 1.98% on the day. Prices are delayed at least 15 minutes.
Does Tandem Diabetes Care pay a dividend?
No. Tandem Diabetes Care does not currently pay a regular cash dividend.
When is Tandem Diabetes Care's next earnings date?
Tandem Diabetes Care is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.27.
Who is Tandem Diabetes Care's CEO?
Mr. John F. Sheridan is the chief executive officer of Tandem Diabetes Care Inc., which has about 2,500 employees.
Has TNDM ever split its stock?
Yes. The most recent TNDM stock split was a 1-for-10 split on Oct 10, 2017.
What is the TNDM 52-week high?
The 52-week high for TNDM is $29.65 and the 52-week low is $12.26. The stock is currently 46.6% below its high.